NAYA Biosciences Inc. (NAYA)
0.38
0.01 (2.70%)
At close: Mar 03, 2025, 3:59 PM
0.39
2.82%
After-hours: Mar 03, 2025, 05:19 PM EST
NAYA Biosciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY10 | FY09 | FY08 | FY07 |
| Cash & Equivalents | 232.42K | 90.14K | 5.68M | 10.1M | 1.24M | 212.24K | 25.76K | 152.4K | 492K | 12.53K | 79.05K | 15.72K | n/a |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | 3.09M | 1.24M | 1.49M | 98.08K | n/a | n/a | n/a | n/a | n/a | n/a | 155K | 450K | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | 240.00 | n/a | n/a | 2.00 | n/a | n/a | -1 | 1.00 | -1 | 9.15K |
| Receivables | 140.55K | 77.15K | 50.47K | 21.7K | 7.56K | 225.9K | 86.7K | 2.79K | 1.35K | 15.71K | 3.06K | 41.7K | n/a |
| Inventory | 264.51K | 263.6K | 287.77K | 265.37K | 101.39K | 43.51K | 58.88K | 85.21K | 65.42K | 69.27K | 63.13K | 70.72K | n/a |
| Other Current Assets | 622.29K | 190.2K | 282.75K | 157.7K | 195.91K | 249.45K | 63.05K | 10.98K | n/a | 1.94K | 46.99K | 73.78K | 3.35K |
| Total Current Assets | 1.26M | 621.09K | 6.31M | 10.54M | 1.54M | 731.11K | 234.38K | 251.39K | 558.77K | 99.44K | 192.24K | 201.92K | 3.35K |
| Property-Plant & Equipment | 4.19M | 1.85M | 2.54M | 211.53K | 194.94K | 34.45K | 15.7K | 15.7K | n/a | 24.43K | 32.84K | 41.24K | n/a |
| Goodwill & Intangibles | 9.97M | n/a | 132.09K | 94.96K | 57.1K | 11.79K | 16.33K | 19.14K | 21.02K | 57.13K | 62.76K | 68.39K | 43.27K |
| Total Long-Term Assets | 17.25M | 3.09M | 4.16M | 404.81K | 252.04K | 46.24K | 32.03K | 34.84K | 21.02K | 81.55K | 250.59K | 559.64K | 52.42K |
| Total Assets | 18.51M | 3.71M | 10.47M | 10.95M | 1.8M | 777.35K | 266.41K | 286.23K | 579.79K | 181K | 442.84K | 761.55K | 55.77K |
| Account Payables | 2.33M | 1.35M | 443.42K | 328.93K | 371.53K | 571.83K | 960.73K | 974.87K | 1.03M | 628.25K | 683.82K | 226.86K | 10.35K |
| Deferred Revenue | 408.77K | 119.88K | 5.9K | 714.29K | 714.29K | 18.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 1.69M | 922.83K | 221.99K | 716.39K | 21.36K | 395.59K | 210.89K | 220.89K | 220.89K | 449.59K | 208.56K | 50K | 49.22K |
| Other Current Liabilities | 3.57M | 946.26K | 581.69K | 527.33K | 393.93K | 2.52M | 3.96M | 3.58M | 3.09M | 1.59M | 2.63M | 614.8K | 3.58K |
| Total Current Liabilities | 8M | 3.34M | 1.25M | 2.29M | 1.5M | 3.5M | 5.13M | 4.77M | 4.34M | 2.66M | 3.52M | 891.66K | 63.15K |
| Long-Term Debt | 4.61M | 1.35M | 1.9M | 58.63K | 436.1K | n/a | 131.72K | 131.72K | n/a | n/a | n/a | 96.46K | 93.55K |
| Other Long-Term Liabilities | 5M | n/a | n/a | n/a | n/a | n/a | -1 | -1 | n/a | n/a | n/a | -1 | n/a |
| Total Long-Term Liabilities | 9.61M | 1.35M | 1.9M | 2.92M | 4.01M | n/a | 131.72K | 131.72K | n/a | n/a | n/a | 96.46K | 93.55K |
| Total Liabilities | 17.61M | 4.69M | 3.16M | 5.2M | 5.51M | 3.5M | 5.26M | 4.9M | 4.34M | 2.66M | 3.52M | 988.12K | 156.7K |
| Total Debt | 6.3M | 2.27M | 2.12M | 775.02K | 457.47K | 395.59K | 342.61K | 352.61K | 220.89K | 449.59K | 208.56K | 146.46K | 142.77K |
| Common Stock | 249.00 | 61.00 | 1.19K | 964.00 | 15.63K | 15.43K | 14.21K | 14.06K | 13.71K | 7.45K | 5.89K | 5.36K | 70.00 |
| Retained Earnings | -57.82M | -49.78M | -38.89M | -32.24M | -23.89M | -21.72M | -18.65M | -17.94M | -15.82M | -6.9M | -6.75M | -2.09M | -214.09K |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shareholders Equity | 892.83K | -977.61K | 7.31M | 5.74M | -3.71M | -2.72M | -4.99M | -4.62M | -3.76M | -2.48M | -3.08M | -226.57K | -100.93K |
| Total Investments | 3.09M | 1.24M | 1.49M | 98.08K | n/a | n/a | n/a | n/a | n/a | n/a | 155K | 450K | n/a |